Medindia

X

Drug Major Cipla's British Arm Buys 51% Equity Stake in Uganda-Based Quality Chemicals

by Dr. Trupti Shirole on  May 23, 2015 at 9:48 AM General Health News   - G J E 4
The British subsidiary of Indian drug major Cipla Ltd has acquired 51% equity stake in Uganda-based Quality Chemicals Ltd for $30 million (Rs.191 crore) in tranches from its current shareholders. As per the agreement that both companies signed on Thursday, Cipla (EU) Ltd will pay $8 million (Rs.51 crore) upfront and the balance amount of Rs.140 crore in five equal installments of $4.41 million annually to the shareholders. This transaction is expected to be completed by July.
Drug Major Cipla's British Arm Buys 51% Equity Stake in Uganda-Based Quality Chemicals
Drug Major Cipla's British Arm Buys 51% Equity Stake in Uganda-Based Quality Chemicals
Advertisement

The 18-year-old Kampala-based Quality Chemicals Ltd imports and distributes pharmaceutical and consumer products in the east African nation. Quality also holds 22% equity stake in another Cipla subsidiary in Uganda - Cipla Quality Chemical Industries Ltd.

Advertisement
The company said in a regulatory filing to the Bombay Stock Exchange (BSE), "Post acquisition, our stake in the Ugandan subsidiary will increase to 62.3% from 51.05% and strengthen our presence in the African market."

Quality's turnover declined to Ugandan shilling 14.85 (approximately $4.98 million) billion in calendar year 2014 from 17.02 billion in 2013.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All